title: Serum neutralizing antibodies against Fusobacterium necrophorum leukotoxin in cattle with experimentally induced or naturally developed hepatic abscesses.
abstract: The relationship between serum-neutralizing antibody against Fusobacterium necrophorum leukotoxin and hepatic abscesses was investigated in cattle fed diets supplemented with or without tylosin. Sixteen cattle (eight each in tylosin and in control groups) were inoculated intraportally with F. necrophorum. Ultrasonographic scanning showed that all control animals developed hepatic abscesses after inoculation. In the tylosin group, two animals were free of abscess by d 7 and one was free by d 14. Leukotoxin-neutralizing antibody titers were low on d 0, but increased (P < .05) markedly after intraportal inoculation in both groups. In a second study, blood was collected at the time of slaughter from 141 feedlot cattle (36 fed diets with tylosin and 105 fed diets without tylosin), and livers were examined for presence or severity of hepatic abscesses at slaughter. The incidences of hepatic abscesses were 32% in the control group and 6% in the tylosin group. Antibody was detected in all animals; however, antibody titers were greater (P < .05) in cattle with abscessed liver than those without, and greater (P < .01) in the nontylosin than in the tylosin group. Abscess score and antibody titer were correlated (r = .34; P < .0001). We conclude that F. necrophorum leukotoxin is highly antigenic and that anti-leukotoxin antibody titer is related to the severity of hepatic abscesses.
authors.affiliation: Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506.
authors.forename: Z L
authors.initials: ZL
authors.lastname: Tan
authors.forename: K F
authors.initials: KF
authors.lastname: Lechtenberg
authors.forename: T G
authors.initials: TG
authors.lastname: Nagaraja
authors.forename: M M
authors.initials: MM
authors.lastname: Chengappa
authors.forename: R T
authors.initials: RT
authors.lastname: Brandt
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy / Q000276:immunology*; D005098:Exotoxins / Q000276:immunology*; D005260:Female; D005674:Fusobacterium Infections / Q000188:drug therapy / Q000276:immunology / Q000662:veterinary*; D005675:Fusobacterium necrophorum / Q000276:immunology*; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology; D008100:Liver Abscess / Q000188:drug therapy / Q000276:immunology / Q000662:veterinary*; D008297:Male; D011897:Random Allocation; D015645:Tylosin / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D005098:Exotoxins; C018579:leukotoxin; D015645:Tylosin